CervoMed Inc expected to post a loss of 63 cents a share - Earnings Preview

CervoMed

05/08/2025 22:28

CervoMed Inc CRVO.OQ CRVO.O is expected to  show a fall in quarterly revenue when it reports  results on August 7 (estimated) for the period ending June 30 2025

The Boston Massachusetts-based  company is expected to report a 47.3% decrease in revenue to $1.734 million from $3.29 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

​LSEG's mean analyst estimate for CervoMed Inc is for a loss of 63 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for CervoMed Inc is $17.50, about 46.7% above its last closing price of $9.33

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.67
-0.66
-0.56
Beat
15
Dec. 31 2025
-0.68
-0.63
-0.80
Missed
-27
Sep. 30 2024
-0.40
-0.41
-0.55
Missed
-33.3​
Jun. 30 2024
-0.26
-0.31
-0.27
Beat
11.8
​​Mar. 31 2024
-0.39
-0.39
-0.41
Missed
-5.1
Dec. 31 2023
-0.29
-0.29
-0.38
Missed
-31​
Sep. 30 2023
-0.95
-0.95
-0.70
Beat
26.3

This summary was machine generated August 5 at 21:28 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)